0001213900-21-007499.txt : 20210208
0001213900-21-007499.hdr.sgml : 20210208
20210208173047
ACCESSION NUMBER: 0001213900-21-007499
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210203
FILED AS OF DATE: 20210208
DATE AS OF CHANGE: 20210208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KIDRON NADAV
CENTRAL INDEX KEY: 0001351779
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35813
FILM NUMBER: 21602717
MAIL ADDRESS:
STREET 1: 142 W. 57TH ST.
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORAMED PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001176309
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980376008
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0831
BUSINESS ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 646-844-1164
MAIL ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: Integrated Security Technologies, Inc.
DATE OF NAME CHANGE: 20040614
FORMER COMPANY:
FORMER CONFORMED NAME: IGUANA VENTURES LTD
DATE OF NAME CHANGE: 20020625
4
1
ownership.xml
X0306
4
2021-02-03
0
0001176309
ORAMED PHARMACEUTICALS INC.
ORMP
0001351779
KIDRON NADAV
1185 AVENUE OF THE AMERICAS
NEW YORK
NY
10036
1
1
1
0
President and CEO
Stock Option (right to buy)
10.40
2021-02-03
4
A
0
150000
0
A
2031-02-03
Common Stock
150000
150000
D
The Stock Option will vest in 4 equal installments as follows: 37,500 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024.
/s/ Nadav Kidron
2021-02-08